Angelica, Co-founder & CEO
Angelica brings a robust background in life sciences, healthcare, business strategy, and innovative genetic engineering research. With over five years experience in the digital healthcare industry, she has witnessed the devastating impact of late and misdiagnosed diabetes. This profound insight drove her to create a groundbreaking technology that redefines early diabetes detection and personalised prevention. Celebrated as a top academic achiever, aspiring Space Doctor, and visionary leader, Angelica is set to transform global chronic disease early identification and prevention.
Rachel brings vast experience in software and AI applications across diverse fields, including novel medical research and community healthcare. At just 16, she began her Bachelor of Engineering degree with First Class Honours, demonstrating remarkable academic prowess. Her participation in various startup programmes has significantly expanded her industry knowledge, complemented by her impactful leadership on various projects at Fisher & Paykel Healthcare, a multi-billion-dollar medical device corporation. Rachel is enthusiastic about leveraging her leadership, passion, and skills to revolutionise the global standard for diabetic screening and preventive healthcare.
We are committed to creating a healthier, safer workforce through real-time monitoring and prevention, ensuring that quality and affordable healthcare is accessible to anyone, anywhere.
We believe that health and safety should be proactive, giving everyone the opportunity to stay healthy before it's too late.
We have partnered with national construction firm to complete our beta trials which is spanning 260 employees across 4 regions.
Through this partnership we can measure BeteCheck's efficiency and impact in the construction industry. Stay tuned for more!
We have been selected to be a part of Australia's Digital Health Festival (DHF) Startup Program!
DHF is an event of unrivalled scale and marks a new era in healthcare, breaking free from outdated practices.
We are excited to announce that we have filed our first patent and are now patent-pending.
Intellectual Property is important to us as it protects our innovative ideas and gives us a competitive edge in the market.
We are fortunate to be a Callaghan Innovations grant recipient! This grant allows us to solidify our position in the market and prepare for capital raising.
Please do not hesitate to reach out if you are interested in learning more or to express interest as an investor.
We won the national HealthTech Startup Challenge! As the Grand Winner we were granted money which will go towards our IP protection and strategy.
This Challenge puts as at the forefront of being a transformative HealthTech venture, whilst validating our business model and solution.
The First Cut Challenge is for founders under 30 to gain financial support and mentoring to launch and grow their business ideas. There’s cash prizes available and an opportunity for one startup that’s ready, to pitch at New Zealand’s largest investor event for up to $1M in investment.
Giants is a virtual validation program that selects founders who are ambitious and curious, with a deep passion for the problem they are solving. Through Giants, we have access to cash prizes, 1:1 mentorship from the best experts, networks, and support.
Copyright © 2024 Ceratec Health LTD - All Rights Reserved.
Powered by GoDaddy